CIK 1481045
Daiwa Securities Group Inc.
Institutional 13F holdings & portfolio
Holdings
1,335
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1201–1250 of 1,335
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| DVAX | DYNAVAX TECHNOLOGIES CORP | 409 | $1K–$15K | SH |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 139 | $1K–$15K | SH |
| VCEL | VERICEL CORP | 163 | $1K–$15K | SH |
| AGIO | AGIOS PHARMACEUTICALS INC | 204 | $1K–$15K | SH |
| NRIX | NURIX THERAPEUTICS INC | 338 | $1K–$15K | SH |
| KOD | KODIAK SCIENCES INC | 177 | $1K–$15K | SH |
| IMCR | IMMUNOCORE HLDGS PLC | 138 | $1K–$15K | SH |
| SNDX | SYNDAX PHARMACEUTICALS INC | 244 | $1K–$15K | SH |
| INVA | INNOVIVA INC | 238 | $1K–$15K | SH |
| EYPT | EYEPOINT INC | 276 | $1K–$15K | SH |
| HROW | HARROW INC | 110 | $1K–$15K | SH |
| UPB | UPSTREAM BIO INC | 180 | $1K–$15K | SH |
| XLC | SELECT SECTOR SPDR TR | 44 | $1K–$15K | SH |
| XLI | SELECT SECTOR SPDR TR | 34 | $1K–$15K | SH |
| ZYME | ZYMEWORKS INC | 186 | $1K–$15K | SH |
| TYRA | TYRA BIOSCIENCES INC | 173 | $1K–$15K | SH |
| TRVI | TREVI THERAPEUTICS INC | 427 | $1K–$15K | SH |
| NVCR | NOVOCURE LTD | 357 | $1K–$15K | SH |
| GMAB | GENMAB A/S | 159 | $1K–$15K | SH |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 692 | $1K–$15K | SH |
| ALVO | ALVOTECH | 1K | $1K–$15K | SH |
| MBX | MBX BIOSCIENCES INC | 150 | $1K–$15K | SH |
| TSHA | TAYSHA GENE THERAPIES INC | 691 | $1K–$15K | SH |
| URGN | UROGEN PHARMA LTD | 160 | $1K–$15K | SH |
| PHAT | PHATHOM PHARMACEUTICALS INC | 260 | $1K–$15K | SH |
| DBC | INVESCO DB COMMDY INDX TRCK | 200 | $1K–$15K | SH |
| ERAS | ERASCA INC | 1K | $1K–$15K | SH |
| USIG | ISHARES TR | 80 | $1K–$15K | SH |
| SEPN | SEPTERNA INC | 149 | $1K–$15K | SH |
| AMPH | AMPHASTAR PHARMACEUTICALS IN | 135 | $1K–$15K | SH |
| RAPP | RAPPORT THERAPEUTICS INC | 121 | $1K–$15K | SH |
| RLAY | RELAY THERAPEUTICS INC | 486 | $1K–$15K | SH |
| GRFS | GRIFOLS S A | 398 | $1K–$15K | SH |
| XLF | SELECT SECTOR SPDR TR | 72 | $1K–$15K | SH |
| ORKA | ORUKA THERAPEUTICS INC | 116 | $1K–$15K | SH |
| ARDX | ARDELYX INC | 754 | $1K–$15K | SH |
| ABCL | ABCELLERA BIOLOGICS INC | 1K | $1K–$15K | SH |
| QURE | UNIQURE NV | 158 | $1K–$15K | SH |
| SPRY | ARS PHARMACEUTICALS INC | 367 | $1K–$15K | SH |
| ANAB | ANAPTYSBIO INC | 75 | $1K–$15K | SH |
| AMLX | AMYLYX PHARMACEUTICALS INC | 266 | $1K–$15K | SH |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 404 | $1K–$15K | SH |
| OMER | OMEROS CORP | 191 | $1K–$15K | SH |
| GLUE | MONTE ROSA THERAPEUTICS INC | 203 | $1K–$15K | SH |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 296 | $1K–$15K | SH |
| XNCR | XENCOR INC | 222 | $1K–$15K | SH |
| SANA | SANA BIOTECHNOLOGY INC | 767 | $1K–$15K | SH |
| ARVN | ARVINAS INC | 252 | $1K–$15K | SH |
| DFTX | MIND MEDICINE MINDMED INC | 242 | $1K–$15K | SH |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 67 | $1K–$15K | SH |